For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

Slayback Pharma LLC

USPTO Granted Patents = 40

EPO Patents = 1

Forward Citations = 164

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Sumitra Ashokkumar Pillai (25 out of 33 patents)

Sushant Omprakash Dube (14 out of 17 patents)

Praveen Kumar Subbappa (13 out of 13 patents)

4. Ajay Kumar Singh (11 out of 14 patents)

5. Girish G Kore (10 out of 13 patents)

6. Satheesh Balasubramanian (10 out of 11 patents)

7. Ashish Anilrao Dubewar (9 out of 11 patents)

8. Hanimi Reddy Bapatu (7 out of 9 patents)

9. Rahul Dhulaji Bhise (7 out of 8 patents)

10. Paras P Jain (7 out of 10 patents)

11. Mahadeo Vasant Mahadik (6 out of 7 patents)

12. Girish Kumar Jain (6 out of 8 patents)

13. Purushottam Sakhahari Pattewar (6 out of 9 patents)

14. Pankaj Kisan Chatki (6 out of 9 patents)

15. Venkateshwar Reddy Keesara (5 out of 7 patents)

Core Competencies:

Apixaban

Edaravone

Netupitant

Palonosetron

Meloxicam

Clonidine

Bendamustine

Neostigmine

Glycopyrrolate

Tofacitinib

Testosterone

Mifepristone

40 patents: Sort by Forward Citations

1. 12521383 - Stable pharmaceutical compositions of apixaban (2026-01-13),

2. 12491178 - Stable pharmaceutical compositions of edaravone (2025-12-09),

3. 12370190 - Stable liquid compositions of netupitant and palonosetron (2025-07-29),

4. 12343330 - Stable pharmaceutical compositions of edaravone (2025-07-01),

5. 12263176 - Pharmaceutical liquid compositions of meloxicam (2025-04-01),

6. 12233049 - Stable pharmaceutical compositions of clonidine (2025-02-25),

7. 12213972 - Stable pharmaceutical compositions of apixaban (2025-02-04),

8. 12208086 - Stable pharmaceutical compositions of bendamustine (2025-01-28),

9. 12194028 - Stable pharmaceutical compositions of apixaban (2025-01-14),

10. 12151020 - Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate (2024-11-26),

11. 12138271 - Pharmaceutical compositions of testosterone (2024-11-12),

12. 12138255 - Pharmaceutical compositions of cabozantinib (2024-11-12),

13. 12133912 - Stable pharmaceutical compositions of succinylcholine chloride (2024-11-05),

14. 12133854 - Pharmaceutical compositions of mifepristone (2024-11-05),

15. 12128089 - Stable liquid compositions of glucagon (2024-10-29),

Company Overview

Slayback Pharma LLC is a biopharmaceutical company based in Princeton, NJ, specializing in the development of innovative drug delivery systems and formulations. The organization focuses on enhancing the therapeutic efficacy of existing medications through advanced technologies, including complex generics and specialty pharmaceuticals. With a commitment to addressing unmet medical needs, Slayback Pharma aims to improve patient outcomes by leveraging its expertise in formulation science and regulatory pathways.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

40 Patents

#33 in Princeton, NJ

#353 in New Jersey

#8,635 in US

#17,087 in the World

Princeton, NJ, United States of America

Slayback Pharma LLC

Forward Citations = 164

43 inventors:

Sumitra Ashokkumar Pillai (25 out of 33 patents)

Sushant Omprakash Dube (14 out of 17 patents)

Praveen Kumar Subbappa (13 out of 13 patents)

4. Ajay Kumar Singh (11 out of 14 patents)

5. Girish G Kore (10 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Slayback Pharma LLC. Retrieved from https://idiyas.com/company/slayback-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…